Schering-Plough to buy Akzo Nobel unit
611168
Schering-Plough Corp. said Monday it will buy the pharmaceuticals division of Akzo Nobel NV for 11 billion euros ($14.5 billion) in cash, acquiring the Organon brand of birth control and strengthening its drug pipeline with an anti-schizophrenia medication.
491995
UBS AG is expected to buy Charles  Schwab Corp.'s institutional research and trading unit for $265  million, the Wall Street Journal said Monday, citing unnamed  people familiar with the matter.
594500
Schering-Plough Corp. SGP.N on  Thursday reported a quarterly profit after a year-ago loss, as  positive foreign exchange trends helped offset poor sales of  its allergy and hepatitis drugs.
723789
Avaya Inc. AV.N, a  telecommunications equipment supplier, on Tuesday said it would  buy Tenovis GmbH & Co. of Germany from private equity firm  Kohlberg Kravis Roberts & Co. for $370 million to expand its  presence in Europe.
24676
Bayer AG forged an alliance for its struggling pharmaceuticals business with US drugmaker Schering-Plough on Monday, cutting costs and marking another step in the German company&#39;s transformation.
104698
AKZO Nobel, the Dutch chemicals group, said yesterday it will start bookbuilding for the flotation of its Organon BioSciences drugs unit on Monday and expects share trading to start on March 27.
541389
BOSTON, Aug. 29 -- Schering-Plough Corp. on Tuesday agreed to pay $435 million and plead guilty to conspiracy to settle a federal investigation into marketing of its drugs for unapproved uses and overcharging Medicaid for certain drugs.
549338
Bayer AG, Germany&#39;s second-biggest drug and chemical maker, formed a marketing partnership with US rival Schering-Plough Corp.
633530
Schering-Plough Corp.  is  seriously considering approaching Bristol-Myers Squibb Co.   about a possible merger, according to a report in The  Star-Ledger newspaper on Friday.
281314
Bayer AG, the German drug and chemical company, has agreed to sell its plasma products business for $590 million in cash and stock to the private U.S. investment groups Cerberus Capital Management and Ampersand ...
407762
Akzo Nobel is selling Crown Paints as one of the conditions for its acquisition of ICI, which owns Dulux.
383867
By Rachel Melcer, St. Louis Post-Dispatch  Feb. 13--Sigma-Aldrich Corp. said Monday that it paid $60 million in cash  to buy Epichem Group Ltd., a British company that makes chemicals for the  semiconductor and solar panel industries.
207050
Perrigo Co., a maker of over-the-counter drugs and supplements for the store-brand market, said Monday that it agreed to buy Israeli generic drug giant Agis Industries Ltd.
590148
Schering-Plough Corp. SGP.N is   seriously considering approaching Bristol-Myers Squibb Co.   BMY.N about a possible merger, according to a report in The   Star-Ledger newspaper on Friday.
349840
Pfizer Inc. PFE.N is close to an  agreement to buy Angiosyn Inc., a biotech start-up working on a  drug to ward off blindness, in a deal potentially valued at  $527 million, the Wall Street Journal reported on Thursday,  citing people familiar with the situation.
245551
Schering-Plough (SGP:NYSE - news - research) Monday announced a broad marketing agreement with Germany&#39;s Bayer (BAY:NYSE - news - research) that both companies said will lead to a more efficient use of their marketing and sales strengths.
456207
Dutch chemical group Akzo Nobel NV   said on Monday it is selling its  pharmaceutical unit Organon BioSciences to Schering-Plough   for 11 billion euros ($14.5 billion).